Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety.
Mathon B, Le Joncour A, Bielle F, Mokhtari K, Boch AL, Peyre M, Amoura Z, Cacoub P, Younan N, Demeret S, Shotar E, Burrel S, Fekkar A, Robert J, Amelot A, Pineton de Chambrun M; PSL BRAIN-BIOPSY STUDY GROUP.
Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield.
Mathon B, Favreau M, Degos V, Amelot A, Le Joncour A, Weiss N, Rohaut B, Le Guennec L, Boch AL, Carpentier A, Bielle F, Mokhtari K, Idbaih A, Touat M, Combes A, Demoule A, Shotar E, Navarro V, Raux M, Demeret S, Pineton De Chambrun M; PSL BRAIN-BIOPSY STUDY GROUP.
Crit Care Med. 2022 Jun 1;50(6):e516-e525. doi: 10.1097/CCM.0000000000005439. Epub 2022 Jan 10.
PMID:34995211
Severity, timeline, and management of complications after stereotactic brain biopsy.
Riche M, Marijon P, Amelot A, Bielle F, Mokhtari K, Chambrun MP, Joncour AL, Idbaih A, Touat M, Do CH, Deme M, Pasqualotto R, Jacquens A, Degos V, Shotar E, Chougar L, Carpentier A, Mathon B.